SCHEMBL6740768

SCHEMBL6740768

NN=C(c1ccccc1)c1ccccc1Br

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CTSL P07711 1/20 0.44
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.40
HTT P42858 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6740766 1.00 ALDH1A1 (0.45) ALDH1A1CTSLNPC1SMN1; SMN2RAB9A
SCHEMBL1141828 0.78 BLM (0.43) ALDH1A1MEN1KMT2AHPGDGAA
SCHEMBL16089348 0.78 BLM (0.43) ALDH1A1MEN1KMT2AHPGDGAA
SCHEMBL6711416 0.78 GSTA1 (0.51) ALDH1A1NPC1SMN1; SMN2MEN1KMT2A
SCHEMBL9853483 0.78 MAPT (0.53) ALDH1A1NPC1SMN1; SMN2RAB9AKMT2A
SCHEMBL6711422 0.78 GSTA1 (0.51) ALDH1A1NPC1SMN1; SMN2MEN1KMT2A
SCHEMBL31019440 0.75 SLC6A3 (0.45) ALDH1A1CTSLNPC1SMN1; SMN2RAB9A
SCHEMBL31019441 0.75 SLC6A3 (0.45) ALDH1A1CTSLNPC1SMN1; SMN2RAB9A
Iodide SCHEMBL27950655 0.75 BLM (0.42) ALDH1A1MEN1KMT2AHPGDGAA
SCHEMBL28041991 0.72 MAPT (0.48) ALDH1A1CTSLNPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686496-B1 4-OXO-2 BUTENOIC ACID AND 3-HYDRAZINO-2,4-DIOXOBUTANOIC ACID DERIVATIVES UNIVERSITY OF CENTRAL FLORIDA 2004-02-03 US disclosed